Fulves-Trant for Breast Cancer CAS 129453-61-8

Product Details
Customization: Available
CAS No.: 129453-61-8
Formula: C32h47f5o3s
Still deciding? Get samples of US$ 100/Bag
Request Sample
Gold Member Since 2024

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Importers and Exporters
The supplier has import and export rights
Exhibition Experience
The supplier had participated in offline trade shows, you can check the Audit Report for more information
to see all verified strength labels (14)
  • Fulves-Trant for Breast Cancer CAS 129453-61-8
  • Fulves-Trant for Breast Cancer CAS 129453-61-8
  • Fulves-Trant for Breast Cancer CAS 129453-61-8
  • Fulves-Trant for Breast Cancer CAS 129453-61-8
  • Fulves-Trant for Breast Cancer CAS 129453-61-8
  • Fulves-Trant for Breast Cancer CAS 129453-61-8
Find Similar Products
  • Overview
  • Product Description
  • Packaging & Shipping
  • About Us
  • FAQ
Overview

Basic Info.

Model NO.
99%
Type
Pharmaceutical Intermediates
Appearance
Powder
Quality
Refined
Colour
White
Product Packaging
Cartons
Melting Point
104-106°c
Boiling Point
674.8±55.0 °c(Predicted)
Density
1.201±0.06 g/cm3(Predicted)
Storage Conditions
2-8°c
Transport Package
Cartons
Specification
1kg
Trademark
Hong Kongda
Origin
Jinan
HS Code
2937230000
Production Capacity
25kg Per Year

Product Description

Product Description

Fluvestran is an intramuscular drug developed by AstraZeneca. It was approved by the US Food and Drug Administration in April 2002 and is applicable to the treatment of estrogen receptor positive metastatic breast cancer in postmenopausal women whose disease is still deteriorating after anti estrogen treatment. Many breast cancer cells have estrogen receptors (ER), which can stimulate the growth of such tumors. Fluvastatin is a "pure" estrogen receptor antagonist that does not have a partial estrogenic like agonist effect. It inhibits the estrogen signaling pathway by binding, chemically blocking, and downregulating ER, and can competitively bind with ER. Its affinity with ER is close to that of estrogen, 100 times that of tamoxifen. It is the only antiestrogen drug that can be widely used in clinical practice after tamoxifen's failure. As an endocrine therapy, this drug does not cause common adverse reactions to chemotherapy, so it has good patient compliance. A number of clinical studies have found that the 250 mg dose of fluoxetine has good therapeutic effect and stable safety in the second-line treatment of advanced breast cancer.

 


Tests
 
SPECIFICATIONS RESULTS

Description
 
White to off-white crystalline powder,no visible evidence of contamination by foreign material White
Crystalline Powder

Color
 
1% of API solution in ethanol (96%) must be
colorless
Conforms

Clarity of the solution
 
1% of AP| solution in ethanol (96%) must be
clear
Conforms

Solubility
 
Practieally insoluble in water,freely soluble in ethanol(96%)and in methylene chloride. Conforms

Identification
IR absorption spectrum of the preparation of the test specimen exhibits maxima only at the same wavelengths as that of a similar preparation of the USP and/or in-hourse reference standard. Conforms
The HPLC retention time of the sample preparation in the assay preparation corresponds to that of the USP and/or in-hourse reference standard. Conforms

Water (Karl Fischer)
 
Not more than 0.5% 0.11%

Residue on ignition
 
Not more than 0.1% <0.1%

Residual solvents Ethyl acetate
 
All the solvents conforms with ICH requirements Not more than 0.5% Conforms
0.12%
Microbiology TAMC-NMT 100 cfu/g (ml)
 
Conforms
 
TYMC-NMT 10 cfu/g (ml)
 
Conforms
 
Enterobacterias resistant to bile- absent in 1g/ml
 
Conforms
 
Pseudomonas aeruginosa - absent in 1 g/ml
 
Conforms
 
Absence of Staphylococcus aureus per 1 g or1 ml
 
Conforms
 

Bacterial endotoxins
 
Not more than0.5 UE/mg Conforms

Heavy metals
 
Not more than0.002% <10ppm

Specific rotation
 
from +108.0°up to +115.09 +112°

Fulves trant isomer A
 
42-48% 44%

Fulves trant isomer B
 
52-58% 56%

6-kcto-fulves trant
 
Not more than 0.1% ND

6,7-fulves trant
 
Not more than 0.1% ND

Fulves trant sulfate
 
Not more than 0.15% ND

Fulves trant extended
 
Not more than 0.15% ND

Fulves trant steroldimer
 
Not more than 0.15% ND

Unspecified impurities
 
Not more than 0.10% 0.06%

Total impurities
 
Not more than 1.0% 0.2%

Assay
 
Fulves trant contains not less than 98.0% and not more than 102.0%calculated on theanhydrous basis. 99.6%

Conclusion
 

The results conform to the Enterprise standard.
 
Packaging & Shipping

Fulves-Trant for Breast Cancer CAS 129453-61-8

About Us

Jinan Hong Kongda Chemical Co., Ltd. is a high-tech enterprise specializing in the production of chemical raw materials and advanced pharmaceutical intermediates integrating scientific research, production and sales. The headquarter is located in Jinan, the capital of Shandong Province with major pharmaceutical province in China which has strong resource advantages.

The company has a complete production system with more than 150 sets of reaction equipment, covering production facilities for various special reactions such as high temperature, ultra-low temperature and hydrogenation. In order to continuously innovate and optimize the process, the company is equipped with an experienced R&D team, and established long-term and stable cooperative relations with many colleges and research institutes.

In order to optimize global resources, protect the environment, and make up for the shortage of some domestic chemical intermediates, the company has established a cooperation center in India to solve domestic shortages.

"Stable quality, price advantage" is our consistent service tenet, and has won a good reputation in the industry′s customer cooperation and service. We hope and look forward to cooperating with you in the future!

Fulves-Trant for Breast Cancer CAS 129453-61-8Fulves-Trant for Breast Cancer CAS 129453-61-8Fulves-Trant for Breast Cancer CAS 129453-61-8Fulves-Trant for Breast Cancer CAS 129453-61-8Fulves-Trant for Breast Cancer CAS 129453-61-8Fulves-Trant for Breast Cancer CAS 129453-61-8

FAQ

Q1  Can i get some samples
A1  Yes, we can supply the free sample, but the shipping cost be paid by our customers.
Q2  How to start orders or make payments
A2 Proforma invoice will be sent first after confirmation of order, enclosed our bank information. Payment by T/T
Q3  How to confirm the Product Quality before placing orders
A3  You can get free samples for some products,you only need to pay the shipping cost or arrange a courier to us and take the samples. You can send us your product specifications and requests, we will manufacture the products according to your requests.
Q4  What's your MOQ
A4  Our MOQ is 1kg. But usually we accept less quantity such as 100g on the condition that sample charge is 100% paid.
Q5  How about delivery leadtime
A5  Delivery lead time: About 3-5 days after payment confirmed. (Chinese holiday not included)
Q6  Is there a discount
A6  Different quantity has different discount.
Q7  How do you treat quality complaint
A7  First of all, our quality control will reduce the quality problem to near zero. If there is a real quality problem caused by us, we will send you free goods for replacement or refund your loss.
Q8  How to contact us
A9  You can chat with us by Trademanager,Skype, Wechat, Whatsapp Online.
       You can choose your interested products and send inquiry to us.
       You can dial our telephone directly or send Email to us., you will get our reply.

 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier